We developed a nano-armored probiotics–rosmarinic acid bioconjugation (EcN-RA@AS/SA), which is capable of effectively delivering probiotics via oral administration and alleviating inflammatory bowel disease (IBD).
Chen et al. (Thu,) studied this question.